Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Clinical Practice Guidelines – Soft Tissue and Visceral Sarcomas

Soft Tissue and Visceral Sarcomas: ESMO-EURACAN Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up

Published in 2018 - Ann Oncol (2018) 29 (Suppl 4): iv51–iv67
Authors: P.G. Casali, N. Abecassis et al., on behalf of the ESMO Guidelines Committee and EURACAN

The 2018 ESMO Clinical Practice Guidelines on soft tissue and visceral sarcomas have been produced by ESMO in partnership with EURACAN, the European Reference Network for rare adult solid cancers. They are conceived to provide the standard approach to diagnosis, treatment and survivorship. Recommended interventions are intended to correspond to the ‘standard’ approaches, according to current consensus among the European multidisciplinary sarcoma community of experts.

New recommendations are given regarding treatment with olaratumab and with eribulin.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings